Collaboration to characterize the immunomodulatory and anti-fibrotic effects of INT-767 in murine models of chronic liver disease

Project Details

StatusActive
Effective start/end date1/02/1731/12/21

Funding

  • Non-EU industry, commerce and public corporations: £355,994.00